Literature DB >> 30559243

Disclosures: Standards of Medical Care in Diabetes-2019.

.   

Abstract

Entities:  

Year:  2019        PMID： 30559243     DOI： 10.2337/dc19-Sdis01

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

1.  Addressing Challenges and Implications of National Surveillance for Racial/Ethnic Disparities in Diabetes.

Authors:  Kunihiro Matsushita; Olive Tang; Elizabeth Selvin
Journal:  JAMA       Date:  2019-12-24       Impact factor: 56.272

2.  Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.

Authors:  Ying Wang; Haiyi Liu; Miaoyan Zheng; Yanhui Yang; Huizhu Ren; Yan Kong; Shanshan Wang; Jingyu Wang; Yingying Jiang; Juhong Yang; Chunyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

3.  SGLT2 inhibitors in T2D and associated comorbidities - differentiating within the class.

Authors:  Guntram Schernthaner; Heinz Drexel; Evgeny Moshkovich; Birute Zilaitiene; Emil Martinka; Leszek Czupryniak; Tamás Várkonyi; Andrej Janež; Kristine Ducena; Katarina Lalić; Tsvetalina Tankova; Martin Prázný; Lea Smirčić Duvnjak; Olga Sukhareva; Harald Sourij
Journal:  BMC Endocr Disord       Date:  2019-06-17       Impact factor: 2.763

Review 4.  Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals.

Authors:  Toshiaki Ohkuma; Yuji Komorita; Sanne A E Peters; Mark Woodward
Journal:  Diabetologia       Date:  2019-07-18       Impact factor: 10.122

5.  Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.

Authors:  Toshiaki Ohkuma; Luc Van Gaal; Wayne Shaw; Kenneth W Mahaffey; Dick de Zeeuw; David R Matthews; Vlado Perkovic; Bruce Neal
Journal:  Diabetes Obes Metab       Date:  2020-01-03       Impact factor: 6.577

6.  Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry.

Authors:  Viveca Ritsinger; Bo Lagerqvist; Pia Lundman; Emil Hagström; Anna Norhammar
Journal:  Diab Vasc Dis Res       Date:  2020 Nov-Dec       Impact factor: 3.291

7.  The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study.

Authors:  Zhiyong Xie; Zhilian Li; Wei Dong; Yuanhan Chen; Ruizhao Li; Yanhua Wu; Huaban Liang; Zhiming Ye; Shuangxin Liu; Wei Shi; Xinling Liang
Journal:  BMC Nephrol       Date:  2020-06-12       Impact factor: 2.388

8.  An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia.

Authors:  Giuseppe Derosa; Angela D'Angelo; Arianna Vanelli; Pamela Maffioli
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-03       Impact factor: 3.168

9.  DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study.

Authors:  Giuditta Benincasa; Monica Franzese; Concetta Schiano; Raffaele Marfella; Marco Miceli; Teresa Infante; Celestino Sardu; Mario Zanfardino; Ornella Affinito; Gelsomina Mansueto; Linda Sommese; Giovanni Francesco Nicoletti; Marco Salvatore; Giuseppe Paolisso; Claudio Napoli
Journal:  Ann Med Surg (Lond)       Date:  2020-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.